| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |